检验医学 ›› 2018, Vol. 33 ›› Issue (11): 1032-1035.DOI: 10.3969/j.issn.1673-8640.2018.011.014

• 实验室管理 • 上一篇    下一篇

上海地区γ-谷氨酰转移酶正确度验证计划调查结果分析

虞啸炫, 欧元祝, 唐立萍, 王美娟, 刘文彬, 葛丹红, 王茗   

  1. 上海市临床检验中心生化室,上海 200126
  • 收稿日期:2017-12-20 出版日期:2018-11-30 发布日期:2018-11-28
  • 作者简介:null

    作者简介:虞啸炫,男,1986年生,学士,主要从事临床生化检验质量控制工作。

  • 基金资助:
    上海市卫生和计划生育委员会科研课题(20154Y0122);上海市第四轮公共卫生三年行动计划重点学科建设卫生检验学(15GWZK0301)

Analysis on the results of gamma-glutamyltransferase trueness verification survey in Shanghai

YU Xiaoxuan, OU Yuanzhu, TANG Liping, WANG Meijuan, LIU Wenbin, GE Danhong, WANG Ming   

  1. Department of Biochemistry,Shanghai Center for Clinical Laboratory,Shanghai 200126,China
  • Received:2017-12-20 Online:2018-11-30 Published:2018-11-28

摘要:

目的 通过国际临床化学和检验医学联合会(IFCC)一级参考方法赋值的γ-谷氨酰转移酶(GGT)正确度控制品将临床实验室的终端结果溯源到酶学的国际单位,同时实现临床实验室GGT结果可比。方法 经过离心过滤处理分装得到4个正确度控制品,经均匀性、稳定性检验符合要求后,通过冷链运输发放给临床实验室,临床实验室对样品连续检测3 d。同时,上海市临床检验中心酶学参考实验室用IFCC一级参考方法为正确度控制品赋值,得到靶值。分别统计2个水平样品不分组的xs、变异系数(CV)及与靶值的偏移;再根据仪器品牌分组统计xsCV及与靶值的偏移。结果 82家实验室检测结果显示:2个水平样品的总体CV均<10%,而与靶值的偏移均<7.3%;82家实验室根据仪器品牌分为8组,其中,罗氏、贝克曼AU系列、迈瑞组的组内CV及与靶值的偏移较小,均<5.6%;贝克曼、日立和东芝组组内CV<6.4%,日立和东芝2个组A水平样品的偏移均>7.2%,B水平样品的偏移均<5.7%,而贝克曼组均>30%。西门子和雅培2个组的CV在10%左右,偏移也在6%左右。采用靶值±5.5%的标准,总体符合率均不满足61%的标准。结论 以IFCC参考方法溯源的GGT检测系统的实验室检测结果与IFCC参考方法赋值的结果偏移较小,而与IFCC参考方法不同的贝克曼配套试剂GGT检测系统的实验室检测结果存在较大的系统偏移。

关键词: γ-谷氨酰转移酶;, 正确度验证, 溯源性

Abstract:

Objective To trace the terminal results of gamma-glutamyltransferase (GGT) determination in clinical laboratories to enzymological international system of units through determining GGT trueness control samples assigned the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) primary reference method,and to achieve the comparability of GGT determination results among clinical laboratories. Methods Four trueness control samples after centrifugation and filtration were transported to clinical laboratories under cold chain,and the samples were determined for 3 d continuously. The trueness control samples were assigned using IFCC primary reference method by Shanghai Center for Clinical Laboratory Enzymological Reference Laboratory,and the target values were obtained. Each sample was not grouped,and the x,s,coefficients of variation (CV) and biases against target values of the 2 samples were evaluated. After each sample was grouped according to instrument brands,the x,s,CV and biases against target values were evaluated as well. Results The results of 82 clinical laboratories showed that the overall CV of the 2 samples were <10%,and the biases against target values were <7.3%. The 82 clinical laboratories were classified into 8 groups according to instrument brands,the within-group CV and biases against target values in Roche,Beckman and Mindray groups were <5.6%. The within-group CV of Beckman,Hitachi and Toshiba groups were <6.4%. The biases of Hitachi and Toshiba groups were >7.2% for A-level sample. The biases for B-level sample was <5.7%. The bias of Beckman group was >30%. The CV of Siemens and Abbott groups were about 10%,and the biases were about 6%. With the target value ±5.5%,the total qualified coincidence rate did not meet the standard of 61%. Conclusions The bias between the results of GGT determination by clinical laboratories tracing back to IFCC reference method and the results assigned using IFCC reference method is small,but the bias of the results of GGT determination by clinical laboratories in Beckman group with IFCC reference method is big.

Key words: Gamma-glutamyltransferase, Trueness verification, Traceability

中图分类号: